Mersana Therapeutics Secures $27,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Mersana Therapeutics
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139
  • Company Description
    Mersana Therapeutics, Inc. (formerly Nanopharma Corp.) is focused on developing novel oncology agents based on Fleximer, a stealth material that enhances the pharmacokinetics and safety of drugs.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The proceeds from this financing will be used to advance Mersana’s Fleximer-based ADC technology and to generate a pipeline of proprietary next-generation ADCs.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    Fidelity BioSciences
  • Venture Investor
    ProQuest Investments
  • Venture Investor
    Rho Ventures
  • Venture Investor
    Harris & Harris Group

Trending on Xconomy